LSL Pharma Group

LSL Pharma Group EBIT Margin

The EBIT Margin (Operating Margin) of LSL Pharma Group (LSL.V) as of Nov 2, 2026 is 0.10 %. In the previous year, EBIT Margin (Operating Margin) was 2.29 % — a change of -95.74% (lower).

EBIT Margin

0.10 %

YoY

-95.74%

Last updated:

EBIT Margin (Operating Margin) of LSL Pharma Group is 2025 0.10 % . EBIT Margin (Operating Margin) of LSL Pharma Group was 2024 2.29 % . It decreases by -95.74% lower compared to the previous year.

LSL Pharma Group's operating (EBIT) margin stands at 0.1%, broadly stable from -0.7% several years earlier.

The LSL Pharma Group EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2020
16.78 CAD
Jan 1, 2021
-0.74 CAD
Jan 1, 2022
-81.28 CAD
Jan 1, 2023
-66.97 CAD
Jan 1, 2024
2.29 CAD
Jan 1, 2025
0.10 CAD
The LSL Pharma Group EBIT Margin history
YEAREBIT MarginYoY
0.10 %-95.74%
2.29 %-103.42%
-66.97 %-17.60%
-81.28 %+10,822.56%
-0.74 %-104.43%
16.78 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

LSL Pharma Group Stock analysis

What does LSL Pharma Group do? LSL Pharma Group, Inc. generates revenue through the development, manufacturing, and distribution of natural health products and dietary supplements in solid dosage forms, as well as sterile ophthalmic pharmaceutical products. The company operates as a pharmaceutical entity specializing in these specific therapeutic and wellness categories to meet market demand. The firm utilizes its subsidiaries, including Steri-Med Pharma Inc., LSL Laboratory Inc., and Groupe Immobilier LSL inc., to support its core operations. These entities facilitate the company's ability to produce and distribute its specialized pharmaceutical and supplement offerings effectively within its operational framework. LSL Pharma Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LSL Pharma Group stock

EBIT Margin (Operating Margin) of LSL Pharma Group is 0.10 % in 2025.

EBIT Margin (Operating Margin) of LSL Pharma Group changed from 2.29 % to 0.10 %, representing a -95.74% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) LSL Pharma Group since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s LSL Pharma Group with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — LSL Pharma Group

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — LSL Pharma Group